Related Experiment Video
Updated: Mar 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Improving Prognostic Web Calculators: Violation of Preferential Risk Independence
Farrokh Alemi1,2, Cari Levy3, Bruce A Citron4
11 The District of Columbia Veteran Administration Medical Center , Washington.
Background:
Web-based applications are available for prognostication of individual patients. These prognostic models were developed for groups of patients. No one is the average patient, and using these calculators to inform individual patients could provide misleading results.
Objective:
This article gives an example of paradoxical results that may emerge when indices used for prognosis of the average person are used for care of an individual patient.
Methods:
We calculated the expected mortality risks of stomach cancer and its associated comorbidities. Mortality risks were calculated using data from 140,699 Veterans Administration nursing home residents.
Results:
On average, a patient with hypertension has a higher risk of mortality than one without hypertension. Surprisingly, among patients with lung cancer, hypertension is protective and reduces risk of mortality. This paradoxical result is explained by how group-level, average prognosis could mislead individual patients. In particular, average prognosis of lung cancer patients reflects the impact of various comorbidities that co-occur in lung cancer patients. The presence of hypertension, a relatively mild comorbidity of lung cancer, indicates that more serious comorbidities have not occurred. It is not that hypertension is protective; it is the absence of more serious comorbidities that is protective. The article shows how the presence of these anomalies can be checked through the mathematical concept of preferential risk independence.
Conclusion:
Instead of reporting average risk scores, web-based calculators may improve accuracy of predictions by reporting the unconfounded risks.
Related Concept Videos
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Survival Analysis
Hazard Rate

